Resmed Inc. buy Morgan Stanley
Start price
21.10.25
/
50%
€230.40
Target price
21.10.26
€261.08
Performance (%)
-15.39%
Price
09.04.26
€194.95
Summary
This prediction is currently active. The price of Resmed Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -15.39%. This prediction currently runs until 21.10.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | 0.309% | 0.309% |
| iShares Core DAX® | 3,07 % | 0,49 % |
| iShares Nasdaq 100 | 2,88 % | 0,08 % |
| iShares Nikkei 225® | 5,98 % | 3,03 % |
| iShares S&P 500 | 2,23 % | 0,05 % |
Comments by Morgan_Stanley for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) had its price target raised by analysts at Morgan Stanley from $298.00 to $304.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat